
US state Hawaii announced Friday it had accepted a $700 million settlement in its case against US pharmaceutical company Bristol-Myers Squibb (BMS) and subsidiaries of French drug group Sanofi over the blood thinner Plavix.
The state alleged the companies misled consumers about the benefit of using the drug, in a case that has been in courts for more than a decade.
‘This landmark settlement is a major victory for the state of Hawaii,’ governor Josh Green said.
BMS and Sanofi have agreed to pay equal shares of the settlement by June 9, bringing an end to 12 years of litigation, according to legal filings.
Per media reports, the pharma giants lost in court repeatedly and continually appealed. In 2021, a Hawaii court ordered the drugmakers to pay the state $834 million over their marketing claims, which the pharma giants vowed to appeal. In 2024, a Hawaii court again ordered them to pay the state $916 million, which they again vowed to appeal.Â